-
Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity
27 Mar 2025 20:01 GMT
… Therapeutics and former CEO of Arena Pharmaceuticals; Mr. Munshi has been … 10,000,000 shares authorized; 0 shares issued and outstanding at … and 6,186,280 shares issued and outstanding at … )
Weighted-average number of common shares – basic and diluted
23 …
-
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $23.15
02 Feb 2024 15:15 GMT
… weighed in on LBPH shares. Cantor Fitzgerald lifted their … target price on shares of Longboard Pharmaceuticals from … their price target on shares of Longboard Pharmaceuticals from … shareholder Arena Pharmaceuticals Inc sold 3,978,540 shares of Longboard …
-
Pfizer Completes Acquisition of Arena Pharmaceuticals
12 Mar 2022 06:52 GMT
… of its acquisition of Arena Pharmaceuticals, a clinical stage company … immuno-inflammatory diseases.
Arena Pharmaceuticals brings to Pfizer a … acquisition of all outstanding shares, options, and restricted … the acquisition, Arena’s shares of common stock will …
-
Pfizer Completes Acquisition of Arena Pharmaceuticals
11 Mar 2022 13:34 GMT
… of its acquisition of Arena Pharmaceuticals, a clinical stage company … immuno-inflammatory diseases.
Arena Pharmaceuticals brings to Pfizer a … acquisition of all outstanding shares, options, and restricted … the acquisition, Arena’s shares of common stock will …
-
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 Feb 2022 21:05 GMT
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today … , with 25% of the shares vesting on the first designated … the remaining 75% of the shares vesting in 12 substantially … -Term Incentive Plan.
About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a …
-
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 Jan 2022 21:05 GMT
… an amount of 15,111 shares, approved by the Compensation … with 25% of the shares vesting on the first designated … remaining 75% of the shares vesting in 12 substantially … -Term Incentive Plan.
About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a …
-
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21 Dec 2021 13:30 GMT
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today … , with 25% of the shares vesting on the first designated … the remaining 75% of the shares vesting in 12 substantially … -Term Incentive Plan.
About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a …
-
Pfizer to buy Arena Pharmaceuticals in $6.7 billion deal
16 Dec 2021 08:00 GMT
… inked a deal to buy Arena Pharmaceuticals in an all-cash deal … the deal.
Arena's shares soared on the news. They … percent gain. Pfizer's shares also were up nearly 5 …
-
Pfizer spending $6.7B to buy Arena Pharmaceuticals
13 Dec 2021 18:49 GMT
… the boards of both companies.
Shares of Arena nearly doubled after … wrote in a research note.
Arena Pharmaceuticals Inc., based in Park City … of around $85 that the shares had reached in February.
… Pfizer shares climbed nearly 4% to $ …
-
Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals
13 Dec 2021 15:09 GMT
… .
Equities Trading UP
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares shot up 84% to … $91.91. Pfizer agreed to acquire Arena Pharmaceuticals … for $100 per share in an all-cash transaction.
Shares …